Practice transitions: buyer vs seller market in 2025

2025 is a buyer's market for practice transitions. Sellers are desperate.

Valuations have dropped 15-20% from the peak in 2022-2023. Seller financing is back (it died for five years). Earnout terms are longer. Warranties are being waived. You're negotiating from power if you're buying right now.

The DSOs and PE-backed platforms who overleveraged in 2022 are now shedding practices. Banks tightened credit. Interest rates killed the leverage game. Sellers who bet on a 2024 exit are now negotiating 2025 transitions at 40% of their expected price.

If you're thinking about buying a practice, this is the window. Rates might drop later, but seller desperation won't last forever. Once the market stabilizes, valuations tighten again and sellers get picky.

If you're thinking about selling, you're on the wrong side of the cycle. Wait. Buyer inventory will eventually reduce. Supply-demand flips in your favor around mid-2026 or 2027. Three years of patience beats selling now at a haircut.

Don't get caught between. Decide if you're a buyer or holder. Sellers trying to time the bottom are losing.

What Broke the Practice Transition Market

The 2022-2023 dental practice acquisition boom wasn't sustainable. DSOs and private equity groups borrowed cheap money at 2-3% interest rates, bought practices at 8-12× EBITDA multiples, and planned to refinance or exit within 3-5 years at even higher valuations.

Then the Fed raised rates. Suddenly, borrowing costs hit 7-9% for acquisition loans. The math stopped working. A practice generating $300K in EBITDA at a 10× multiple costs $3M to acquire. Finance that at 3% over 10 years, and your debt service is ~$290K annually. Tight, but manageable if you can grow EBITDA by 5-8% per year.

Now finance the same deal at 8%. Your annual debt service jumps to $445K. You're immediately underwater unless you can grow EBITDA by 15-20% annually - and most practices can't. Growth stalls, debt service crushes cash flow, and the buyer either defaults or sells at a loss to escape the trap.

This happened across hundreds of acquisitions in 2022-2023. DSOs that bought aggressively are now quietly offloading underperforming practices. PE-backed platforms that planned to roll up 50-100 practices and sell the portfolio are stuck holding assets they can't exit profitably. Some are filing Chapter 11. Others are doing distressed sales to other consolidators at 40-50 cents on the dollar.

That's why 2025 is a buyer's market. The sellers are motivated by survival, not optimization.

What This Means If You're Buying

If you're an independent dentist or a small group looking to acquire, you've got leverage you haven't had in a decade.

First: valuations are down. Practices that would have sold at 8-10× EBITDA in 2022 are now trading at 6-7× in 2025. That's a 20-30% discount just from market correction. Some distressed sellers are going even lower - 4-5× if they need to exit fast.

Second: seller financing is back. Banks tightened credit, so sellers who want out are offering financing directly. This wasn't common in 2020-2023 because sellers could get all-cash offers from DSOs. Now? They'll hold a note for 30-50% of the purchase price just to close the deal. That gives you better terms, lower upfront cash requirements, and more negotiating power on earnouts and warranties.

Third: earnouts are longer and more flexible. Sellers used to demand full payment at close or within 12 months. Now they're agreeing to 3-5 year earnouts tied to revenue retention or EBITDA performance. If the practice underperforms post-acquisition, you pay less. That shifts risk back to the seller, which is where it should be.

Fourth: You can negotiate warranties. Sellers are waiving reps and warranties on patient retention, accounts receivable, and equipment condition just to get deals done. You'll still want to do your own due diligence, but you're not absorbing liability the way you would have in a hot market.

If you've been waiting for the right time to acquire a practice, this is it. Rates might drop later, but seller desperation is peaking now. Once the distressed inventory clears and the market stabilizes, pricing and terms will tighten again.

What This Means If You're Selling

If you're planning to sell, you're facing the worst market conditions in 10 years. Buyers have options, capital is tight, and valuations are down 15-20% from the peak.

Selling now means accepting a haircut. If you were expecting a 9× EBITDA multiple in 2024, you're looking at 6-7× in 2025. On a practice generating $400K in EBITDA, that's a $800K-1.2M difference in sale price. If you don't need to exit urgently, waiting makes sense.

The market will recover. It always does. Right now, there's a supply glut of practices for sale because distressed sellers are flooding the market. Once that inventory clears (probably by late 2026 or early 2027), supply-demand will rebalance. Buyers will have fewer options, and sellers will regain pricing power. Valuations won't hit 2022 highs again, but they'll stabilize in the 7-9× range for strong practices.

If you can wait 18-24 months, you'll recover $500K-1M in valuation. If you can't wait - maybe you're retiring, dealing with health issues, or facing a partnership dispute - then you need to accept the market as it is and optimize within those constraints. Offer seller financing, tighten your books, and focus on buyers who can close fast.

OPERATOR MATH

Let's model two scenarios: buying a practice in 2025 (buyer's market) versus buying the same practice in 2027 (post-market recovery).

Scenario 1: Buying in 2025 (buyer's market)
- Practice EBITDA: $350,000
- Valuation multiple: 6.5×
- Purchase price: $2,275,000
- Seller financing: 40% ($910,000 at 6% over 7 years)
- Bank loan: 60% ($1,365,000 at 8.5% over 10 years)
- Annual debt service: $103,000 (seller note) + $206,000 (bank loan) = $309,000/year
- Cash flow after debt service: $350,000 EBITDA - $309,000 debt = $41,000/year

You're cash-flow positive from day one with $41K annual margin to cover owner compensation, reinvestment, or further debt paydown.

Scenario 2: Buying in 2027 (post-recovery market)
- Practice EBITDA: $350,000 (assume flat growth)
- Valuation multiple: 8.5×
- Purchase price: $2,975,000
- Seller financing: 20% ($595,000 at 6.5% over 5 years)
- Bank loan: 80% ($2,380,000 at 7% over 10 years - rates dropped slightly)
- Annual debt service: $134,000 (seller note) + $340,000 (bank loan) = $474,000/year
- Cash flow after debt service: $350,000 EBITDA - $474,000 debt = -$124,000/year

You're underwater by $124K annually. You'd need to grow EBITDA to $500K+ within 2-3 years just to break even on debt service. That's aggressive growth in a mature practice.

Net difference: Buying in 2025 saves you $700K in purchase price and $165K annually in debt service. Over 10 years, that's $1.65M in cumulative cash flow advantage - plus the lower risk of default if the practice underperforms post-acquisition.

For sellers, the math is reversed. Selling in 2025 at 6.5× costs you $700K versus waiting until 2027 and selling at 8.5×. If you can afford to wait, the valuation recovery is worth $500K-1M depending on your practice size.

THE TAKEAWAY

If you're a buyer (immediate actions):

1. Start looking now. Pull listings from practice brokers (ADS South, Henry Schein Practice Transitions, PARMA). Target practices with EBITDA over $300K in markets where you're willing to relocate or expand.
2. Get pre-approved for acquisition financing this month. Even if you're not ready to buy yet, knowing your borrowing capacity and terms gives you speed when the right deal appears. Sellers favor buyers who can close in 60-90 days.
3. Negotiate aggressively. Offer 6-7× EBITDA with 30-40% seller financing over 5-7 years. Request earnouts tied to patient retention. Push for extended due diligence periods (60 days minimum). Sellers are motivated - use it.

If you're a seller (strategic decisions):

1. Run a valuation analysis this month. Hire a practice appraiser or broker to give you a realistic 2025 sale price. Compare it to your expected price 18-24 months from now (assume 8-9× EBITDA in a stabilized market). Calculate the gap.
2. If the gap is $500K or more and you can afford to wait, don't sell in 2025. Spend the next 18 months tightening operations, improving EBITDA, and preparing for a 2027 exit. You'll recover most of the lost valuation.
3. If you need to exit now, optimize for speed and certainty. Offer seller financing (30-40% of purchase price), accept slightly lower multiples, and target buyers who can close in 60-90 days. A fast sale at 6.5× beats a dragged-out negotiation at 7× that falls apart.

The practice transition market is cyclical. Right now, buyers have the advantage. Sellers should wait unless they can't. Buyers should move aggressively before the window closes. The market will stabilize, but timing matters. Don't get stuck on the wrong side of the cycle.